The Company is engaged in the research, development, and commercialization of women's healthcare and endocrinology products, including those that treat and are intended to treat infertility, endometriosis, dysmenorrhea and hormonal deficiencies.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
ROIC greater than 100%. Trailing price/earnings ratio of 3.95. Market Cap of 72.06 million. Trading near 52 week low. Zero long term debt per morningstar report. Focus on women?s healthcare and endocrinology products.